ConductScience.org, home

Trial · NCT02250443

Results by group68

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Number of Participants With Adverse Events as a Measure of Safety and TolerabilityBYM338Death0Participants
Number of Participants With Adverse Events as a Measure of Safety and TolerabilityBYM338Serious adverse events (SAE)2Participants
Number of Participants With Adverse Events as a Measure of Safety and TolerabilityBYM338Adverse Events (AE)10Participants
Changes From Baseline in Lean Body Mass (LBM) by Dual-Energy X-ray Absorptiometery (DXA)BYM338Day 10Standard Deviation 0Percentage Change in LBM
Changes From Baseline in Lean Body Mass (LBM) by Dual-Energy X-ray Absorptiometery (DXA)BYM338Day 574.292Standard Deviation 2.7480Percentage Change in LBM
Changes From Baseline in Lean Body Mass (LBM) by Dual-Energy X-ray Absorptiometery (DXA)BYM338Day 1135.552Standard Deviation 3.6066Percentage Change in LBM
Changes From Baseline in Lean Body Mass (LBM) by Dual-Energy X-ray Absorptiometery (DXA)BYM338Day 1697.463Standard Deviation 4.5687Percentage Change in LBM
Changes From Baseline in Lean Body Mass (LBM) by Dual-Energy X-ray Absorptiometery (DXA)BYM338Day 3656.919Standard Deviation 2.9669Percentage Change in LBM
Changes From Baseline in Lean Body Mass (LBM) by Dual-Energy X-ray Absorptiometery (DXA)BYM338Day 5336.885Standard Deviation 3.7894Percentage Change in LBM
Changes From Baseline in Lean Body Mass (LBM) by Dual-Energy X-ray Absorptiometery (DXA)BYM338Day 7290.727Standard Deviation NAPercentage Change in LBM
Pharmacokinetics (PK) Parameter of Cmin From Multiple i.v. DosingBYM338Day 29 (n=10)13.4Standard Deviation 5.01ng/mL
Pharmacokinetics (PK) Parameter of Cmin From Multiple i.v. DosingBYM338Day 85 (n=10)24.1Standard Deviation 13.1ng/mL
Pharmacokinetics (PK) Parameter of Cmin From Multiple i.v. DosingBYM338Day 169 (n=10)26.3Standard Deviation 15.9ng/mL
Pharmacokinetics (PK) Parameter of Cmin From Multiple i.v. DosingBYM338Day 253 (n=9)28.8Standard Deviation 12.1ng/mL
Pharmacokinetics (PK) Parameter of Cmin From Multiple i.v. DosingBYM338Day 337 (n=10)24.4Standard Deviation 14.6ng/mL
Pharmacokinetics (PK) Parameter of Cmin From Multiple i.v. DosingBYM338Day 421 (n=9)24.5Standard Deviation 11.5ng/mL
Pharmacokinetics (PK) Parameter of Cmin From Multiple i.v. DosingBYM338Day 505 (n=8)28.3Standard Deviation 10.6ng/mL
Pharmacokinetics (PK) Parameter of Cmin From Multiple i.v. DosingBYM338Day 589 (n=6)39.8Standard Deviation 30.2ng/mL
Pharmacokinetics (PK) Parameter of Cmin From Multiple i.v. DosingBYM338Day 673 (n=2)20.5Standard Deviation 1.98ng/mL
Pharmacokinetics (PK) Parameter of Cmin From Multiple i.v. DosingBYM338Day 757 (n=1)20.3Standard Deviation NAng/mL

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02250443/results